2 天前 - … Vietnam) in patients with mild/moderate COVID-19 and the presumed efficacy in
Phase 3 … contribute as a new treatment option for patients suffering from COVID-19 symptoms. …

3 天前 - … treatment. While a definitive cure remains elusive, efforts are underway to alleviate
the burden of long COVID through pharmacological … during the treatment of COVID-19 can …

4 天前 - … of the hardest hit from the COVID‑19 pandemic, leaving many patients overburdened
… their ongoing treatment delayed. We aimed at studying the effects of COVID‑19 pandemic …

6 天前 - … Data regarding all clinical features such as symptoms correlated with CoViD-19,
medical history, clinical treatment, intake of food with supplements and changes in lifestyle was …

6 天前 - … outcomes of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19. …
to provide strategies for clinical treatment.Methods: Older COVID-19 patients (age ≥ 65) …

6 天前 - … To obtain the most recent clinical studies of subcutaneous injection of tocilizumab
for the treatment of patients with severe COVID-19, we also searched the preprint platforms …

6 天前 - … pharmacological treatments that have significantly improved the management of
COVID-19. … A key obstacle faced by patients and researchers is the post-COVID-19 condition, …

7 天前 - … Despite concerns that difficulty or delays in providing care during the pandemic
could have led to shifts from non-pharmacological treatments to greater opioid prescribing, we …

7 天前 - … to treat obesity, has seen dynamic utilization trends over recent years, and the
subsequent pharmacological … and 2021, coinciding with the COVID-19 pandemic. The surgical …

8 天前 - … Our aim is to provide critical insights to those managing COVID-19 treatment in …
the recommended treatment for ambulatory COVID-19 patients with mild-to-moderate COVID-19 …